Globus Medical Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Dive Deeper Into the Activities Behind the Analysis
This Globus Medical Value Chain Analysis gives you a clear, structured view of how the company creates value across support and primary activities. The page already shows a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
Globus Medical's firm infrastructure is built for a regulated, high-complexity medtech model, where quality systems, finance, legal, and compliance drive execution. In FY2025, the NuVasive integration kept governance and reporting tight as the business scaled to roughly $2.5 billion in net sales. That matters because FDA scrutiny, product traceability, and post-merger controls can affect margins, launch speed, and risk.
Human Resource Management
In fiscal 2025, Globus Medical depends on engineers, clinical specialists, manufacturing talent, and field sales teams that can work inside surgery-support settings. Training matters because its implants, robotic platforms, and enabling technologies need skilled surgeon and hospital support. Strong human resource management lowers service errors, speeds product adoption, and helps protect margins in a high-touch medtech business.
Technology Development
Globus Medical's technology development drives value by funding spinal implants, motion preservation, robotics, navigation, and imaging that help it differentiate products and win surgeon trust. R&D also supports product refreshes and clinical evidence, which matters because hospital adoption depends on proof, not just features. In FY2025, that innovation engine stayed tied to faster launches and stronger procedural support across its spine and enabling-technology portfolio.
Procurement
Globus Medical's procurement must secure high-spec metals, electronics, sterile packaging, and precision parts for implants and robotic systems. Strong sourcing keeps unit cost down, but it also protects quality and traceability, which matter for regulated surgical devices. It also helps keep inventory flexible so products are ready when surgery schedules change fast. Supplier control is a key risk check because any shortage can disrupt both implant and robotics output.
Globus Medical's Backbone: Supporting $2.5B in FY2025 Sales
Globus Medical's support activities in FY2025 kept a complex, regulated spine and robotics platform running at scale. Firm infrastructure and compliance supported about $2.5 billion in net sales, while HR and training helped field and clinical teams support surgeon use. R&D and procurement stayed central to product quality, speed, and traceability.
| FY2025 item | Value |
|---|---|
| Net sales | ~$2.5 billion |
| Support focus | Compliance, talent, R&D, sourcing |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
In fiscal 2025, Globus Medical's inbound logistics centered on raw materials, machined parts, electronic components, and sterile packaging for its implant and robotic lines. Strong supplier control matters because one missing part can delay a case-specific kit and a scheduled surgery.
The same flow also helps Globus Medical hold tighter inventory and respond to short-notice hospital demand. For a medtech maker with 2025 sales demand tied to regulated, surgeon-driven cases, reliable inbound timing is a direct cost and service lever.
Operations
Operations turns Globus Medical design work into finished implants, instruments, and enabling tech through manufacturing, assembly, testing, sterilization, and packaging. In fiscal 2025, that step is where R&D spend becomes revenue-generating product flow, so quality control and line uptime matter as much as innovation. It also supports fast launches across a broad spinal and orthopedic portfolio, which helps Globus Medical keep products reliable in the OR.
Outbound Logistics
Globus Medical's outbound logistics move implants, instrument trays, and capital systems to hospitals and ambulatory surgery centers in the right case-ready mix, so scheduled spine and orthopedic procedures can start on time. Because many orders are tied to surgery dates, stock placement near key sites helps cut delays and lost cases. In 2025, this matters more as the company serves a broad global install base and a mix of high-value, procedure-specific products.
Marketing and Sales
In FY2025, Globus Medical's marketing and sales centered on surgeon education, clinical evidence, and field teams that support spine and musculoskeletal accounts. This model links implants and robotic systems to clinical workflow, which helps drive adoption in surgery settings and shortens the path from trial to routine use.
Account coverage also matters because each sale often needs hospital-level buy-in, training, and follow-up. That makes the sales force a direct part of product uptake, not just a lead generator.
Service
Globus Medical's service covers case support, technical training, field service, and post-sale help for robotic and enabling platforms. It helps surgeons use the systems with more confidence, keeps uptime high, and reduces friction in the OR. That support also drives pull-through for implants, disposable supplies, and recurring service revenue tied to installed base use.
Globus Medical's FY2025: Robotic Growth, Tight Execution, Strong Demand
In FY2025, Globus Medical's primary activities were driven by case-ready implants, robotic systems, and surgeon support, with net sales around $2.5 billion and R&D near 7% of sales. Marketing and sales stayed field-led, while service and training protected installed-base use and pulled through recurring product demand. Operations and outbound logistics mattered most because each hospital case depends on tight timing and product availability.
| FY2025 | Primary activity | Key data |
|---|---|---|
| 2025 | Primary activities | Net sales ~$2.5B; R&D ~7% |
Get Your Copy
Globus Medical Reference Sources
This is the actual Globus Medical Value Chain Analysis document you'll receive upon purchase – no surprises, just the full professional version. The preview below is taken directly from the complete report, so what you see is exactly what you get. After checkout, you'll unlock the full, detailed Value Chain Analysis in its entirety.
Frequently Asked Questions
Technology development and surgeon-facing service drive it most. Globus Medical competes through 4 support activities and 5 primary activities that convert R&D into implant, robotic, and navigation revenue. The 2023 NuVasive acquisition expanded scale, while the company's spine-focused portfolio and Excelsius platform improve differentiation and account pull-through.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.